Leukotriene receptor agonist (LTRA)
Showing 1 - 25 of 8,262
Asthma Trial (BDA MDI, AS MDI)
Not yet recruiting
- Asthma
- BDA MDI
- AS MDI
- (no location specified)
Aug 15, 2022
Asthma in Children Trial in Xi'an (Fluticasone propionate inhaled aerosol)
Not yet recruiting
- Asthma in Children
- Fluticasone propionate inhaled aerosol
-
Xi'an, Shanxi, ChinaDepartment of Pediatrics, Xijing Hospital
Jun 29, 2021
Nephrotic Syndrome Trial in Multan (Montelukast)
Completed
- Nephrotic Syndrome
-
Multan, PPunjab, PakistanDepartment of Pediatric Nephrology, The Children's Hospital and
Mar 23, 2021
Status Asthmaticus Trial in Nashville (Montelukast Oral Granules, Albuterol, Corticosteroid)
Not yet recruiting
- Status Asthmaticus
- Montelukast Oral Granules
- +2 more
-
Nashville, TennesseeMonroe Carell Jr. Children's Hospital at Vanderbilt
Apr 5, 2023
Moderate Covid19 Trial in Riyadh (Leukotriene Receptor Antagonist, Placebo)
Recruiting
- Moderate Covid19
- Leukotriene Receptor Antagonist
- Placebo
-
Riyadh, Saudi ArabiaKing Abdulaziz Medical city, MNGHA
May 5, 2021
Allergic Rhinitis Due to Weed Pollen, Montelukast Trial in Beijing (Start taking Montelukast Sodium Tablets 10mg quaque die
Completed
- Allergic Rhinitis Due to Weed Pollen
- Montelukast
- Start taking Montelukast Sodium Tablets 10mg quaque die orally two weeks before peak pollen count.
- +2 more
-
Beijing, Beijing, ChinaBeijing Tongren Hospital
Sep 1, 2021
Incidence of Retained Gastric Food on Endoscopy
Not yet recruiting
- Gastric Content Aspiration
- Esophagogastroduodenoscopy
- (no location specified)
May 16, 2023
Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,
Not yet recruiting
- Breast Cancer
- +2 more
- Abemaciclib
- +5 more
-
Boston, Massachusetts
- +7 more
Aug 14, 2023
Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases Trial in Boston (Belumosudil, Fluticasone,
Not yet recruiting
- Bronchiolitis Obliterans Syndrome
- +3 more
- Belumosudil
- +4 more
-
Boston, Massachusetts
- +3 more
Jun 27, 2023
Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)
Completed
- Hair Diseases
- +2 more
- DA-OTC-002
-
Manaus, BrazilHospital Oscar Nicolau
Oct 20, 2023
Pulmonary Arterial Hypertension Trial in Tempe (Prostacyclin Receptor Agonist)
Recruiting
- Pulmonary Arterial Hypertension
- Prostacyclin Receptor Agonist
-
Tempe, ArizonaCelerion
Aug 16, 2022
Effects of GLP-1 Agonists on Gastric Volume
Not yet recruiting
- Diabetes
- +3 more
- Gastric Ultrasound
-
Charleston, South CarolinaMedical University of South Carolina
May 10, 2023
Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)
Not yet recruiting
- Type 2 Diabetes
- Diabetes Mellitus, Type 2
- (no location specified)
Feb 6, 2023
Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
Not yet recruiting
- Thrombopoietin Receptor Agonist
- (no location specified)
May 4, 2023
Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)
Recruiting
- Seasonal Allergic Rhinitis
- LP-003 dose 1
- +2 more
-
Beijing, Beijing, China
- +16 more
Sep 18, 2023
Metabolic-associated Fatty Liver Disease, Type 2 Diabetes Trial (Empagliflozin, Dulaglutide, Empagliflozin and Dulaglutide)
Not yet recruiting
- Metabolic-associated Fatty Liver Disease
- Type 2 Diabetes
- Empagliflozin
- +2 more
- (no location specified)
Oct 1, 2022
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese Trial (Semaglutide)
Not yet recruiting
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Obese
- (no location specified)
Apr 6, 2023
Diabetes, Type 2 Trial in Amsterdam (device, drug, other)
Recruiting
- Diabetes Mellitus, Type 2
- ReCET
- +2 more
-
Amsterdam, North-Holland, NetherlandsAmsterdam UMC
Aug 9, 2023
Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)
Recruiting
- Neuroendocrine Tumors
- Gallium-68 NODAGA-JR11
-
Beijing, Beijing, China
- +1 more
Jul 27, 2022
Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,
Recruiting
- Glaucoma, Suspect
- Aberration, Corneal Wavefront
- Low dosage selective alpha-2 receptor agonists topical eyedrop
- High dosage selective alpha-2 receptor agonists topical eyedrop
-
Banhā, QA, EgyptAhmed Abdelshafy
Jan 2, 2023
Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide
Recruiting
- Type 2 Diabetes
- Obesity
- Semaglutide 1.34 MG/ML [Ozempic]
- +3 more
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
May 19, 2022